Literature DB >> 2932064

Ultrasound study of ovarian and uterine morphology in women with polycystic ovary syndrome before, during and after treatment with cyproterone acetate and ethinyloestradiol.

S Venturoli, R Paradisi, E Saviotti, E Porcu, R Fabbri, L F Orsini, L Bovicelli, C Flamigni.   

Abstract

Women with the polycystic ovary syndrome were treated cyclically for two years with an oral oestrogen/progestogen combination of 50 mg of cyproterone acetate and 0.05 mg of ethinyloestradiol. Ovarian volume, ovarian texture and uterine size were monitored by ultrasound before, during and after treatment. Menstrual rhythm, ovulation and the degree of hirsutism were also studied clinically. A significant decrease in the ovarian volume and in the number of cystic areas was observed during treatment. Hirsutism was also markedly improved. Some of these beneficial effects persisted after treatment was stopped. The number of subjects who had regular, ovulatory cycles increased after stopping treatment. Growth of uterine muscle occurred during treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932064     DOI: 10.1007/BF02133945

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN: 0170-9925


  12 in total

1.  Clinical assessment of body hair growth in women.

Authors:  D FERRIMAN; J D GALLWEY
Journal:  J Clin Endocrinol Metab       Date:  1961-11       Impact factor: 5.958

2.  Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive.

Authors:  J R Givens; R N Andersen; W L Wiser; S A Fish
Journal:  J Clin Endocrinol Metab       Date:  1974-05       Impact factor: 5.958

Review 3.  The polycystic ovary syndrome.

Authors:  S S Yen
Journal:  Clin Endocrinol (Oxf)       Date:  1980-02       Impact factor: 3.478

4.  The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women.

Authors:  M Frölich; H L Vader; S T Walma; H A De Rooy
Journal:  J Steroid Biochem       Date:  1980-01       Impact factor: 4.292

5.  Ultrasound study of ovarian morphology in women with polycystic ovary syndrome before and during treatment with an oestrogen/progestogen preparation.

Authors:  S Venturoli; R Paradisi; E Saviotti; S Barnabé; E Porcu; R Fabbri; C Flamigni
Journal:  Arch Gynecol       Date:  1983

6.  Cyproterone acetate in the treatment of hirsutism.

Authors:  P Ylöstalo; L Laakso; L Viinikka; O Ylikorkala; R Vihko
Journal:  Acta Obstet Gynecol Scand       Date:  1981       Impact factor: 3.636

7.  Therapy of androgenetic sympatomatology with cyproterone acetate and ethinyl estradiol.

Authors:  A E Schindler; K Mangold; E Friedrich; E Keller; R Göser
Journal:  Arch Gynakol       Date:  1978-05-12

8.  Medical implications of ultrasonically detected polycystic ovaries.

Authors:  M Swanson; E E Sauerbrei; P L Cooperberg
Journal:  J Clin Ultrasound       Date:  1981 May-Jun       Impact factor: 0.910

9.  The role of ultrasound in the study of polycystic ovarian disease.

Authors:  L Parisi; M Tramonti; S Casciano; A Zurli; O Gazzarrini
Journal:  J Clin Ultrasound       Date:  1982-04       Impact factor: 0.910

10.  The treatment of essential hirsutism in women with cyproterone acetate and ethinyl estradiol. Clinical and endocrine effects in 10 cases.

Authors:  H Frey; A Aakvaag
Journal:  Acta Obstet Gynecol Scand       Date:  1981       Impact factor: 3.636

View more
  2 in total

1.  Endocrine and clinical effects of spironolactone in female hyperandrogenism.

Authors:  R Siegberg; P Ylöstalo; T Laatikainen; R Pelkonen; U H Stenman
Journal:  Arch Gynecol       Date:  1987

2.  Non-contraceptive benefits of oral hormonal contraceptives.

Authors:  Adolf E Schindler
Journal:  Int J Endocrinol Metab       Date:  2012-12-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.